Article info
PDFClinical science
Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results
- Correspondence to Dr John F. Payne, Palmetto Retina, West Columbia, South Carolina, USA; jpayne{at}palmettoretina.com
Citation
Long-term outcomes of treat-and-extend ranibizumab with and without navigated laser for diabetic macular oedema: TREX-DME 3-year results
Publication history
- Received February 27, 2020
- Revised March 31, 2020
- Accepted April 2, 2020
- First published April 17, 2020.
Online issue publication
January 21, 2021
Article Versions
- Previous version (21 January 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.